ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,514.64
      0.10%
      US Tech 100
      19,446.00
      -0.17%
      Dow Jones
      39,400.49
      0.17%
      Brent Oil
      86.195
      -0.29%
      Bitcoin
      60,404.09
      -2.62%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. TransCode Therapeutics Inc (RNAZ)

      7. TransCode Therapeutics Inc (RNAZ) Financials

      TransCode Therapeutics Inc

      TransCode Therapeutics Inc (RNAZ)

      NASDAQ
      0.94
      -0.0194
      (-2.02%)
      Closed July 02 4:00PM
      Delayed by 15 minutes
      0.9642
      0.0242
      ( 2.57% )
      Pre Market: 9:19AM
      Delayed by 15 minutes

      TransCode Therapeutics Inc Financial Summary

      The current RNAZ market cap is 6.38M. The company's latest EPS is USD -2.8006 and P/E is -0.34.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -4.9M-5.13M-5.33M-4.06M-3.29M
      Net Income -4.82M-4.34M-5.3M-4.09M-3.33M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -457k-726k-6.15M-18.67M-19.42M
      Net Income -607k-2.34M-6.84M-17.57M-18.55M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 5.59M5.88M10.23M5.17M7.29M
      Total Liabilities 5.83M3.79M5.79M3.53M2.71M
      Total Equity -237k2.09M4.44M1.64M4.58M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 204k1.06M22.94M7.59M5.17M
      Total Liabilities 1.31M4.46M2.53M4.35M3.53M
      Total Equity -1.11M-3.41M20.4M3.24M1.64M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -4.51M-8.91M-12.41M-18.07M-3.94M
      Investing -13k-31k-35k-36k-4k
      Financing 1.18M7.54M14.93M15.91M6.09M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -509k-493k-5.27M-15.76M-18.07M
      Investing N/A N/A -252k-101k-36k
      Financing 500k1.12M25.52M5k15.91M

      Stats and Ratios

      Market Cap 6.38M
      Price to Earnings Ratio -0.34
      Price to Sales Ratio 0
      Price to Cash Ratio 2.25
      Price to Book Ratio 3.79
      Dividend Yield -

      Share Statistics

      Shares Outstanding 6.62M
      Average Volume (1 week) 139.25k
      Average Volume (1 Month) 324.42k
      52 Week Change -98.95%
      52 Week High 128.00
      52 Week Low 0.42
      Spread (Intraday) 0.02 (2.51%)

      Company Info

      Company Name TransCode Therapeutics Inc
      Address 1209 orange street
      wilmington, delaware 19801
      Website https://www.transcodetherapeutics.com
      Industry pharmaceutical preparations (2834)